End-of-day quote
Shenzhen S.E.
03:30:00 21/05/2024 am IST
5-day change
1st Jan Change
8.08
CNY
-1.70%
-3.12%
-23.99%
INKON Life Technology Co., Ltd.'s Equity Buyback announced on February 5, 2021, has expired with 2,509,317 shares, representing 0.39% for CNY 50 million.
The company expired its plan on January 11, 2022.
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
25/04
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
21/04
CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.
01/04
CI
INKON Life Technology Co., Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.
05/02
CI
INKON Life Technology Co., Ltd. authorizes a Buyback Plan.
05/02
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
26/23/26
CI
Inkon Life Technology Co., Ltd. Announces Directorate Appointments
10/23/10
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
29/23/29
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
27/23/27
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
24/23/24
CI
INKON Life Technology to Set Up Medical Ecological Park for 566 Million Yuan
18/23/18
MT
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. completed the acquisition of Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders.
14/22/14
CI
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. agreed to acquire Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders for CNY 87.7 million.
27/22/27
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
25/22/25
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
23/22/23
CI
INKON Life Technology Co., Ltd. announced that it expects to receive CNY 999.999998 million in funding from Qingdao Yingkang Medical Investment Co., Ltd.
12/22/12
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
28/22/28
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22/22/22
CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.
11/22/11
CI
INKON Life Technology Co., Ltd.'s Equity Buyback announced on February 5, 2021, has expired with 2,509,317 shares, representing 0.39% for CNY 50 million.
11/22/11
CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.
04/22/04
CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
28/21/28
CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.
12/21/12
CI
INKON Life Technology Co., Ltd.(XSEC:300143) added to S&P Global BMI Index
20/21/20
CI
Qingdao Yingkang Medical Investment Co., Ltd. acquired Hangzhou Yikang Traditional Chinese Medicine Tumor Hospital Co., Ltd. from INKON Life Technology Co., Ltd. for CNY 1.3 million.
13/21/13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.
More about the company
Last Close Price
8.08
CNY
Average target price
10.12
CNY
Spread / Average Target
+25.25%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1